Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Yu, Yang ^a   Walia, Vijay ^a,b   Elble, Randolph C ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; DOXORUBICIN; FIBRONECTIN; NERVE CELL ADHESION MOLECULE; PROTEIN CLCA2; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL MIGRATION; CELL STIMULATION; CELL STRESS; CLCA2 GENE; CLCA4 GENE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE LOSS; GENE SILENCING; GENETIC MARKER; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PREDICTIVE VALUE; RECURRENCE FREE SURVIVAL; TUMOR INVASION; UPREGULATION;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHLORIDE CHANNELS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; OXIDATIVE STRESS;

EID: 84891299486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083943     Document Type: Article

References (38)

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752
2. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, et al. (2001) A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 61: 5697-5702 (Pubitemid 32769079)
3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874 (Pubitemid 32878711)
4. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, et al. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 106: 13820-13825
5. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116-4124
6. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715 (Pubitemid 351636299)
7. Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL (2011) TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res 71: 4707-4719
8. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, et al. (2008) Loss of Ecadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654
9. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674
10. Liu S, Wicha MS (2010) Targeting breast cancer stem cells. J Clin Oncol 28: 4006-4012
11. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659
12. Hsu YM, Chou CY, Chen HH, Lee WY, Chen YF, et al. (2007) IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness. J Cell Physiol 210: 626-636 (Pubitemid 46185032)
13. Fuller CM, Ji HL, Tousson A, Elble RC, Pauli BU, et al. (2001) Ca(2+)-activated Cl(2) channels: a newly emerging anion transport family. Pflugers Arch 443 Suppl 1: S107-110 (Pubitemid 33086963)
14. Agnel M, Vermat T, Culouscou JM (1999) Identification of three novel members of the calcium-dependent chloride channel (CaCC) family predominantly expressed in the digestive tract and trachea. FEBS Lett 455: 295-301 (Pubitemid 29333055)
15. Walia V, Ding M, Kumar S, Nie D, Premkumar LS, et al. (2009) hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation. Cancer Res 69: 6624-6632
16. Walia V, Yu Y, Cao D, Sun M, McLean JR, et al. (2012) Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis. Oncogene 31: 2237-2246
17. Bustin SA, Li SR, Dorudi S (2001) Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer. DNA Cell Biol 20: 331-338 (Pubitemid 32692436)
18. Yang B, Cao L, Liu B, McCaig CD, Pu J (2013) The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1. PLoS One 8: e60861
19. Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, et al. (2002) Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 277: 35509-35515
20. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270
21. Marshall AM, Pai VP, Sartor MA, Horseman ND (2009) In vitro multipotent differentiation and barrier function of a human mammary epithelium. Cell Tissue Res 335: 383-395
22. Walia V, Elble RC (2010) Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion. Stem Cells Dev 19: 1175-1182
23. Cheng HC, Abdel-Ghany M, Elble RC, Pauli BU (1998) Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J Biol Chem 273: 24207-24215 (Pubitemid 28435768)
24. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, et al. (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123: 725-731
25. Lin X, Shang X, Manorek G, Howell SB (2013) Regulation of the Epithelial- Mesenchymal Transition by Claudin-3 and Claudin-4. PLoS One 8: e67496
26. Wang X, Zheng M, Liu G, Xia W, McKeown-Longo PJ, et al. (2007) Kruppellike factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 67: 7184-7193 (Pubitemid 47206546)
27. Zhang JT, Jiang XH, Xie C, Cheng H, Da Dong J, et al. (2013) Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer. Biochim Biophys Acta 1833: 2961-2969
28. Xie C, Jiang XH, Zhang JT, Sun TT, Dong JD, et al. (2013) CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 32: 2282-2291, 2291 e2281-2287
29. Yurtsever Z, Sala-Rabanal M, Randolph DT, Scheaffer SM, Roswit WT, et al. (2012) Self-cleavage of human CLCA1 protein by a novel internal metalloprotease domain controls calcium-activated chloride channel activation. J Biol Chem 287: 42138-42149
30. Mundhenk L, Alfalah M, Elble RC, Pauli BU, Naim HY, et al. (2006) Both cleavage products of the mCLCA3 protein are secreted soluble proteins. J Biol Chem 281: 30072-30080 (Pubitemid 44537015)
31. Pawlowski K, Lepisto M, Meinander N, Sivars U, Varga M, et al. (2006) Novel conserved hydrolase domain in the CLCA family of alleged calcium-activated chloride channels. Proteins 63: 424-439
32. Bothe MK, Mundhenk L, Kaup M, Weise C, Gruber AD (2011) The murine goblet cell protein mCLCA3 is a zinc-dependent metalloprotease with autoproteolytic activity. Mol Cells 32: 535-541
33. Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, et al. (2013) Calciumactivated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc Natl Acad Sci U S A 110: E1026- 1034
34. Liu W, Lu M, Liu B, Huang Y, Wang K (2012) Inhibition of Ca(2+)-activated Cl(2) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Cancer Lett 326: 41-51
35. Ruiz C, Martins JR, Rudin F, Schneider S, Dietsche T, et al. (2012) Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PLoS One 7: e43265
36. Derichs N (2013) Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis. Eur Respir Rev 22: 58-65
37. Kolbe EW, Tamm S, Hedtfeld S, Becker T, Tummler B, et al. (2013) CLCA4 variants determine the manifestation of the cystic fibrosis basic defect in the intestine. Eur J Hum Genet 21: 691-694
38. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, et al. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65 (Pubitemid 32060682)